Interferon Therapy in Recurrent Renal Carcinoma
- 12 January 1983
- journal article
- Published by Wiley in Acta Medica Scandinavica
- Vol. 213 (3) , 221-223
- https://doi.org/10.1111/j.0954-6820.1983.tb03721.x
Abstract
Seven patients with recurrent renal carcinoma, who had previously been treated with progesterone and vinblastine for progressive disease, were treated with human leukocyte interferon (HuIFN alpha). Five patients received daily escalating i.m. IFN doses from 4 X 10 up to 16 X 10(6) U during a minimum of 4 weeks, while two patients received intralesional IFN, 20 X 10(6) U/dose. No serious side-effects were observed. No tumor response was found in any of these patients.Keywords
This publication has 15 references indexed in Scilit:
- APPLICATION OF HUMAN LEUCOCYTE INTERFERON IN PATIENTS WITH CARCINOMA OF THE UTERINE CERVIXThe Lancet, 1981
- APPLICATION OF HUMAN LEUCOCYTE INTERFERON IN PATIENTS WITH TUMOURS OF THE HEAD AND NECKThe Lancet, 1981
- APPLICATION OF HUMAN LEUCOCYTE INTERFERON IN PATIENTS WITH URINARY BLADDER PAPILLOMATOSIS, BREAST CANCER, AND MELANOMAThe Lancet, 1981
- Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant LymphomaAnnals of Internal Medicine, 1980
- Role of G0-G1 arrest in the inhibition of tumor cell growth by interferon.Proceedings of the National Academy of Sciences, 1980
- Interferon (II): Learning About How It WorksScience, 1979
- Interferon Therapy in Multiple MyelomaActa Medica Scandinavica, 1979
- Interferon Therapy in Neoplastic DiseaseActa Medica Scandinavica, 1978
- Interferons: Anti-neoplastic drugs?Annals of Hematology, 1977
- Effect of human leukocyte interferon on the growth of human osteosarcoma cells in tissue cultureInternational Journal of Cancer, 1977